Medications for Psoriatic Arthritis

30 results
  • abrilada - adalimumab - afzb

    (Adalimumab-Afzb)
    Pfizer Laboratories Div Pfizer Inc
    Abrilada is a TNF blocker indicated for moderate-to-severe rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, juvenile idiopathic arthritis (age 2+), Crohn's disease (age 6+), ulcerative colitis, chronic plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis in adults.
  • acthar - repository corticotropin injection

    (Repository Corticotropin)
    Mallinckrodt Ard Llc
    Acthar Gel treats infantile spasms in children under 2 and acute multiple sclerosis exacerbations in adults. Also indicated for rheumatic, collagen, dermatologic, allergic, ophthalmic, and respiratory disorders, and nephrotic syndrome edema.
  • amjevita - adalimumab - atto injection

    (Adalimumab-Atto)
    Amgen, Inc
    TNF blocker for rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis in adults and eligible pediatric patients.
  • avsola - infliximab - axxq injection, powder, lyophilized, for solution

    (Infliximab-Axxq)
    Amgen, Inc
    Avsola is a TNF blocker for moderately to severely active Crohn's disease and ulcerative colitis (adults and children ≥6 years), rheumatoid arthritis (with methotrexate), ankylosing spondylitis, psoriatic arthritis, and chronic severe plaque psoriasis in adults.
  • bimzelx - bimekizumab injection, solution

    (Bimekizumab)
    Ucb, Inc.
    BIMZELX treats adults with moderate-to-severe plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, non-radiographic axial spondyloarthritis with objective signs of inflammation, and moderate-to-severe hidradenitis suppurativa.
  • cimzia - certolizumab pegol

    (Certolizumab Pegol)
    Ucb, Inc.
    CIMZIA is a TNF blocker that treats moderately to severely active Crohn's disease, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, non-radiographic axial spondyloarthritis, and plaque psoriasis in adults, and polyarticular juvenile idiopathic arthritis in patients 2 years and older.
  • cosentyx - secukinumab injection

    (Secukinumab)
    Novartis Pharmaceuticals Corporation
    Cosentyx treats moderate-to-severe plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, non-radiographic axial spondyloarthritis, enthesitis-related arthritis, and moderate-to-severe hidradenitis suppurativa in eligible adults and pediatric patients.
  • cyltezo - adalimumab - adbm

    (Adalimumab-Adbm)
    Boehringer Ingelheim Pharmaceuticals, Inc.
    Cyltezo is a TNF blocker indicated for rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, plaque psoriasis, Crohn's disease, ulcerative colitis, hidradenitis suppurativa, non-infectious uveitis in adults, and juvenile idiopathic arthritis and uveitis in pediatric patients.
  • enbrel - etanercept

    (Etanercept)
    Immunex Corporation
    Enbrel is a TNF blocker for adults with rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and plaque psoriasis; and for children 2+ with polyarticular juvenile idiopathic arthritis and juvenile psoriatic arthritis, and children 4+ with plaque psoriasis.
  • hadlima - adalimumab - bwwd solution

    (Adalimumab-Bwwd)
    Organon Llc
    HADLIMA is a TNF blocker for adults and children with moderately to severely active rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis. Also indicated for juvenile idiopathic arthritis in patients 2 years and older.